The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung Cancer
Status:
Terminated
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the overall survival of patients with advanced non
small cell lung cancer treated with docetaxel as single therapy versus docetaxel in
combination with either gemcitabine or vinorelbine or in combination with capecitabine.